Oncology Nursing Emergencies: Recognition and Response | Megha Shah, DNP, FNP, OCN
Oncology nursing is not always a crisis. Most shifts in an infusion center or on a medical oncology unit are about building relationships, managing symptoms, delivering treatments, and teaching patients how to take care of themselves at home. But every oncology nurse will, at some point, face a patient who is deteriorating fast. Knowing what to do before it happens is what separates a good outcome from a bad one.
There are five oncology emergencies that every nurse caring for a cancer patient should be able to recognize and respond to: neutropenic fever, tumor lysis syndrome, superior vena cava syndrome, hypercalcemia of malignancy, and malignant spinal cord compression. None of them is rare in the oncology population. All of them are potentially fatal when the response is delayed.
Neutropenic Fever
Neutropenic fever is the most common oncologic emergency nurses encounter in the outpatient and inpatient setting. It is defined as a single oral temperature of 38.3°C (101°F) or higher, or a temperature of 38.0°C (100.4°F) sustained for one hour or longer in a patient with an absolute neutrophil count (ANC) below 500 cells/mcL, or an ANC below 1,000 cells/mcL that is expected to decline further.
Why it is dangerous. When the neutrophil count is critically low, the immune system cannot mount a normal response to infection. Classic signs of infection — redness, swelling, pus — may be absent or blunted. Sepsis can develop rapidly and without warning, and mortality rates rise significantly with each hour of delayed antibiotic therapy.
Assessment priorities. When a patient presents with fever, obtain a thorough history: what chemotherapy regimen and when was the last dose, what the most recent ANC was, and whether the patient has any implanted devices such as a port or central line. Perform a full physical exam looking for an infectious source — skin, lungs, oropharynx, perirectal area (inspect visually, do not examine digitally in neutropenic patients). Obtain blood cultures from two sites, including from any central line, before starting antibiotics. Obtain a chest X-ray, urinalysis, and urine culture.
Escalation. Neutropenic fever is a medical emergency. The Infectious Diseases Society of America guidelines recommend that broad-spectrum antibiotics — typically an antipseudomonal beta-lactam — be started within 60 minutes of presentation. Do not wait for culture results. Risk stratification tools such as the MASCC score help identify low-risk patients who may be candidates for oral antibiotic management, but this decision belongs to the provider. As a nurse, your job is to recognize the fever, obtain the cultures, and communicate the urgency to the team without delay. Please don’t forget to follow institutional guidelines for your institution-appropriate escalation procedures.
Tumor Lysis Syndrome
Tumor lysis syndrome (TLS) occurs when cancer cells are destroyed rapidly — most often by chemotherapy — and release their intracellular contents into the bloodstream. The result is a dangerous constellation of metabolic disturbances: hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia.
Why it is dangerous. Hyperkalemia can cause fatal cardiac arrhythmias. Hyperphosphatemia binds calcium, causing hypocalcemia that manifests as tetany, seizures, and cardiac dysrhythmias. Uric acid crystals can precipitate in the renal tubules and cause acute kidney injury. TLS can be spontaneous — occurring before treatment — or treatment-induced, and it is most commonly associated with hematologic malignancies including Burkitt lymphoma, acute lymphoblastic leukemia, and diffuse large B-cell lymphoma.
Assessment priorities. High-risk patients should be identified before treatment begins. Risk factors include high tumor burden, rapidly proliferating malignancy, elevated baseline uric acid or creatinine, and certain targeted agents such as venetoclax. Nurses caring for high-risk patients should monitor electrolytes and renal function labs closely — in inpatient settings, this may be every four to six hours during peak risk periods. Watch for clinical signs of electrolyte disturbance: muscle cramps, tetany, palpitations, altered mental status, decreased urine output.
Escalation. Prevention is the priority. High-risk patients are typically hydrated aggressively with IV fluids before and during treatment to increase urine output and flush uric acid. Allopurinol reduces uric acid production, and rasburicase rapidly converts uric acid to a more soluble form in high-risk or established TLS. When labs indicate metabolic derangement, escalate immediately. Hyperkalemia with ECG changes and symptomatic hypocalcemia are emergencies requiring real-time intervention.
Superior Vena Cava Syndrome
Superior vena cava (SVC) syndrome occurs when the flow of blood through the SVC — the large vessel that returns blood from the upper body to the heart — is obstructed. In oncology, the most common cause is external compression by a tumor, most often lung cancer or lymphoma, though thrombus formation related to a central venous catheter can also cause SVC obstruction.
Why it is dangerous. Obstruction impairs venous return from the head, neck, arms, and upper chest. Cerebral and airway edema can develop. In severe cases, SVC syndrome can cause respiratory compromise and altered mental status. It is typically a subacute to acute presentation, meaning symptoms develop over days to weeks, but it can progress to respiratory failure.
Assessment priorities. The classic clinical picture includes facial and upper extremity edema that is worse in the morning and improves when the patient is upright, visible distension of veins in the neck and chest wall, and dyspnea. Some patients report headache, visual changes, or a sense of fullness in the head. Assess for stridor, respiratory distress, and level of consciousness. Do not place IV lines or draw blood from the upper extremities in a patient with suspected SVC syndrome — use the lower extremities instead.
Escalation. A patient with new-onset facial or upper extremity edema, visible chest vein collaterals, or dyspnea in the context of a known thoracic malignancy or central venous catheter needs prompt evaluation. Notify the provider immediately. Imaging — typically contrast-enhanced CT of the chest — is used to confirm the diagnosis. Treatment depends on the underlying cause and may include steroids to reduce edema, endovascular stenting, radiation, or chemotherapy for the underlying malignancy. Elevating the head of the bed improves venous drainage and provides symptomatic relief while the evaluation is underway.
Hypercalcemia of Malignancy
Hypercalcemia — a serum calcium above 10.5 mg/dL or an ionized calcium above 1.3 mmol/L — is the most common metabolic emergency in cancer patients. It occurs in approximately 10% to 30% of cancer patients at some point during their disease course and is most frequently associated with breast cancer, lung cancer, multiple myeloma, and squamous cell carcinomas.
Why it is dangerous. The mechanisms include bone resorption driven by tumor-secreted parathyroid hormone-related protein (PTHrP), direct osteolytic lesions in the bone, and less commonly, overproduction of calcitriol in lymphoma. Elevated calcium affects the neuromuscular system, the kidneys, and the cardiovascular system. The mnemonic “bones, moans, groans, and psychic overtones” captures the breadth of symptoms: bone pain, constipation and nausea, muscle weakness, and neurological changes including confusion and lethargy. At severely elevated levels, hypercalcemia can cause coma and cardiac arrest.
Assessment priorities. Assess for the gradual, nonspecific symptoms that patients often attribute to their cancer or treatment: increasing fatigue, nausea, constipation, confusion, polyuria, and polydipsia. Because these overlap with so many other oncologic issues, hypercalcemia is often caught on routine labs rather than clinical recognition. When calcium is found to be elevated on labs, correlate with the clinical picture and notify the provider. ECG changes — shortened QT interval, prolonged PR interval — may be present with significant hypercalcemia.
Escalation. Symptomatic hypercalcemia requires IV hydration with normal saline to promote renal calcium excretion. Bisphosphonates — most commonly zoledronic acid — inhibit osteoclast-mediated bone resorption and are the standard treatment for moderate to severe hypercalcemia of malignancy. Denosumab is used in patients with renal insufficiency or bisphosphonate-refractory disease. Response to treatment takes 24 to 72 hours. Patients with altered mental status or cardiac involvement need monitoring in a setting with continuous telemetry.
Malignant Spinal Cord Compression
Malignant spinal cord compression (MSCC) occurs when a tumor — either a metastatic lesion or primary spinal tumor — compresses the spinal cord or cauda equina. It affects 5% to 10% of cancer patients and is most commonly associated with prostate, breast, lung, and renal cancers, as well as multiple myeloma and lymphoma.
Why it is dangerous. Cord compression causes ischemia and, if untreated, permanent neurological damage. The window for neurological recovery closes quickly. Patients who are ambulatory at the time of treatment have a significantly better prognosis for maintaining mobility than those who are already paraplegic at presentation. Early recognition and rapid intervention are what determine functional outcome.
Assessment priorities. Back pain is the presenting symptom in the vast majority of cases — often weeks before neurological deficits appear. Any cancer patient with new or worsening back pain warrants evaluation, particularly those with a history of malignancies that commonly metastasize to bone. Red flag symptoms that warrant urgent evaluation include bilateral lower extremity weakness, sensory changes below a dermatomal level, bowel or bladder dysfunction such as urinary retention or incontinence, and the Lhermitte sign — a shooting electrical sensation down the spine with neck flexion. Assess gait, lower extremity strength, and perianal sensation.
Escalation. A patient with new neurological symptoms — weakness, sensory changes, or bowel and bladder dysfunction — in the setting of a known cancer diagnosis needs emergent imaging. MRI of the entire spine is the imaging modality of choice. Do not wait. Time from symptom onset to treatment initiation directly affects the probability of neurological recovery. High-dose dexamethasone is typically started immediately to reduce edema around the cord while imaging and treatment planning are underway. Definitive treatment may include radiation therapy, surgical decompression, or both, depending on tumor histology and the patient’s overall condition.
These five emergencies share something important: they are all more manageable when caught early. As an oncology nurse, you are often the first person to notice that something has changed — a patient looks more confused than usual, is walking differently, or mentions symptoms they did not think were worth reporting. Trust that observation. Speak up. The skill set that makes oncology nursing hard also makes it one of the highest-impact roles in medicine.